Oncology

Content will be added shortly.

Sl No. Title Authors Journal Name Publication Year
1 Pre-Menopausal Women With Breast Cancers Having High AR/ER Ratios in the Context of Higher Circulating Testosterone Tend to Have Poorer Outcomes. (IF:5.555) Rajarajan S, Korlimarla A, Alexander A, Anupama CE, Ramesh R, Srinath BS, Sridhar TS, Prabhu JS. Frontiers in endocrinology. 2021
2 miRNAs: Critical mediators of breast cancer metastatic programming. (IF: 3.905) Nair MG, Somashekaraiah VM, Ramamurthy V, Prabhu JS, Sridhar TS. Experimental Cell Research. 2021
3 Gender disparity in COVID-19: Role of sex steroid hormones. (IF:2.285) Lipsa A, Prabhu JS. Asian Pacific journal of tropical medicine. 2021
4 High expression of ACE2 in HER2 subtype of breast cancer is a marker of poor prognosis. (Cite score- 1.2) Nair MG, Prabhu JS, Sridhar TS. Cancer treatment and research communications. 2021
5 Expression of HER2 and EGFR Proteins in Advanced Stage High-grade Serous Ovarian Tumors Show Mutual Exclusivity. (IF:2.762) Crasta J, Ravikumar G, Rajarajan S, Gali S, Kulkarni KA, Vallikad E, Prabhu J. International Journal of Gynecological Pathology 2021
6 Engagement and social acceptance in genome editing for human benefit: Reflections on research and practice in a global context. Sebastián Barbosa*, Lea Pare Toe*, Delphine Thizy*, Manjulika Vaz*, Lucy Carter *equal contributors Wellcome Open Res 2020
7 miR-18a Activates Wnt Pathway in ER-positive Breast Cancer and Is Associated With Poor Prognosis (IF:4.452) Nair MG, Prabhu JS, Korlimarla A, Rajarajan S, Hari PS, Kaul R, Alexander A, Raghavan R, Srinath BS, Sridhar TS Cancer Med 2020
8 Expression of HER2 and EGFR Proteins in Advanced Stage High-grade Serous Ovarian Tumors Show Mutual Exclusivity (IF:2.762) Crasta J, Ravikumar G, Rajarajan S, Gali S, Kulkarni KA, Vallikad E, Prabhu J Int J Gynecol Pathol 2020
9 Living with cancer: Urgent need for emotional health support Alexander A, Murthy RS Indian J Cancer 2020
10 Identification of colorectal cancers with defective DNA damage repair by immunohistochemical profiling of mismatch repair proteins, CDX2 and BRCA1 (Cite score- 1.63) Rajarajan S, Anupama CE, Jose B, Correa M, Sengupta S, Prabhu JS Mol Clin Oncol 2020
11 miR-18a activates Wnt pathway in ER-positive breast cancer and is associated with poor prognosis (IF:4.452) Nair MG, Prabhu JS, Korlimarla A, Rajarajan S, P S H, Kaul R, Alexander A, Raghavan R, Srinath BS, Sridhar TS Cancer Med 2020
12 High frequency of exon 20 S768I EGFR mutation detected in malignant pleural effusions: A poor prognosticator of NSCLC D'Souza G, Dhar C, Kyalanoor V, Yadav L, Sharma M, Nawaz S M, Srivastava S Cancer Rep (Hoboken) 2020
13 Prognostic role of microRNA 182 and microRNA 18a in locally advanced triple negative breast cancer (IF:3.240) Bajaj R, Tripathi R, Sridhar TS, Korlimarla A, Choudhury KD, Suryavanshi M, Mehta A, Doval DC PLoS One 2020
14 Cystic Neutrophilic Granulomatous Mastitis: A Clinicopathological Study With 16s rRNA Sequencing for the Detection of Corynebacteria in Formalin-Fixed Paraffin-Embedded Tissue Naik MA, Korlimarla A, Shetty ST, Fernandes AM, Pai SA Int J Surg Pathol 2019
15 RhoC: a fascinating journey from a cytoskeletal organizer to a Cancer stem cell therapeutic target Thomas P, Pranatharthi A, Ross C, Srivastava S J Exp Clin Cancer Res 2019